Tamsulosin: 3-Year Long-Term Efficacy and Safety in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Analysis of a European, Multinational, Multicenter, Open-Label Study

Tamsulosin: 3-year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: analysis of a European, multinational, multicenter, open-label study.

Current Opinion in Urology ◽

10.1097/00042307-200005000-00030 ◽

2000 ◽

Vol 10 (3) ◽

pp. 264-265

Author(s):

Andrea Tubaro

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Efficacy And Safety ◽

Benign Prostatic Obstruction ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Urinary Tract Symptoms ◽

High-Dose Terazosin Therapy (5 mg) in Korean Patients with Lower Urinary Tract Symptoms with or without Concomitant Hypertension: A Prospective, Open-Label Study

Yonsei Medical Journal ◽

10.3349/ymj.2007.48.6.994 ◽

2007 ◽

Vol 48 (6) ◽

pp. 994 ◽

Author(s):

Cheol Kwak ◽

Jeong Ki Lee ◽

Ja Hyeon Ku

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

High Dose ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Urinary Tract Symptoms ◽

Concomitant Hypertension ◽

Can We Decide the Optimal Initial Treatment for Male Lower Urinary Tract Symptoms Patients with Overactive Bladder by the Most Bothersome Symptom? A Randomized, Prospective, Open-Label Study

Urologia Internationalis ◽

10.1159/000365335 ◽

2014 ◽

Vol 93 (3) ◽

pp. 338-343 ◽

Author(s):

Jong Hyun Yun ◽

Jae Heon Kim ◽

Jae Ho Kim ◽

Sang Wook Lee ◽

Hee Jo Yang ◽

...

Keyword(s):

Urinary Tract ◽

Overactive Bladder ◽

Initial Treatment ◽

Lower Urinary Tract ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Urinary Tract Symptoms ◽

Bothersome Symptom ◽

MP-09.09 Efficacy and Safety of Combination of Alfuzosin and Low Dose Udenafil Once Daily versus Monotherapy in Patients with Comorbid Lower Urinary Tract Symptoms and Erectile Dysfunction: Randomized Prospective Open-label Study

Urology ◽

10.1016/j.urology.2011.07.211 ◽

2011 ◽

Vol 78 (3) ◽

pp. S97 ◽

Author(s):

D. Cho ◽

J. Seo ◽

J. Kim ◽

H. Seo ◽

J. Lee ◽

...

Keyword(s):

Erectile Dysfunction ◽

Lower Urinary Tract ◽

Low Dose ◽

Efficacy And Safety ◽

Open Label ◽

Once Daily ◽

Open Label Study ◽

Label Study ◽

Urinary Tract Symptoms ◽

754 Efficacy and safety of combination of alfuzosin and low dose udenafil once daily versus monotherapy in patients with comorbid lower urinary tract symptoms and erectile dysfunction: Randomized prospective open-label study

European Urology Supplements ◽

10.1016/s1569-9056(12)60751-9 ◽

2012 ◽

Vol 11 (1) ◽

pp. e754-e754a

Author(s):

D.Y. Kim ◽

Y.J. Park ◽

L.H. Sung ◽

J.C. Kim

Keyword(s):

Erectile Dysfunction ◽

Lower Urinary Tract ◽

Low Dose ◽

Efficacy And Safety ◽

Open Label ◽

Once Daily ◽

Open Label Study ◽

Label Study ◽

Urinary Tract Symptoms ◽

Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study)

BJU International ◽

10.1111/bju.14209 ◽

2018 ◽

Vol 122 (2) ◽

pp. 317-325 ◽

Cited By ~ 2

Author(s):

Giuseppe Morgia ◽

Giuseppe Vespasiani ◽

Rosaria M. Pareo ◽

Salvatore Voce ◽

Massimo Madonia ◽

...

Keyword(s):

Urinary Tract ◽

Clinical Study ◽

Lower Urinary Tract ◽

Serenoa Repens ◽

Benign Prostatic Obstruction ◽

Open Label ◽

Urinary Tract Symptoms ◽

Lower Urinary ◽

Phase Iv

Efficacy and Safety of Tamsulosin for Treating Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled, Open-Label Non-Inferiority Study

Korean Journal of Urology ◽

10.4111/kju.2012.53.3.178 ◽

2012 ◽

Vol 53 (3) ◽

pp. 178 ◽

Cited By ~ 7

Author(s):

Hyo Serk Lee ◽

Sae Woong Kim ◽

Seung-June Oh ◽

Myung-Soo Choo ◽

Kyu-Sung Lee

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽

643 Efficacy and safety of simultaneous administration of mirodenafil once daily and an alpha blocker in men with unsatisfactory improvement of lower urinary tract symptoms despite the alpha blocker mono therapy: A multicenter, open-label, prospective study

European Urology Supplements ◽

10.1016/s1569-9056(12)60640-x ◽

2012 ◽

Vol 11 (1) ◽

pp. e643-e643a

Author(s):

C.Y. Oh ◽

J.S. Cho ◽

C. Yoo ◽

D.Y. Yang ◽

B.H. Chung ◽

...

Keyword(s):

Urinary Tract ◽

Prospective Study ◽

Lower Urinary Tract ◽

Simultaneous Administration ◽

Efficacy And Safety ◽

Open Label ◽

Once Daily ◽

Alpha Blocker ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea

Korean Journal of Urology ◽

10.4111/kju.2014.55.5.335 ◽

2014 ◽

Vol 55 (5) ◽

pp. 335 ◽

Author(s):

Ki Hak Moon ◽

Phil Hyun Song ◽

Dae Yul Yang ◽

Nam Cheol Park ◽

Soo Woong Kim ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Urinary Tract Symptoms ◽

Adrenoceptor Blocker ◽

Re: Long-Term Safety and Efficacy of Single-Tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-Label Extension

The Journal of Urology ◽

10.1016/j.juro.2016.05.020 ◽

2016 ◽

Vol 196 (2) ◽

pp. 502-503

Author(s):

Steven A. Kaplan

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Absorption System ◽

Open Label ◽

Safety And Efficacy ◽

Urinary Tract Symptoms ◽

Open Label Extension ◽